Bank of New York Mellon Corp - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 44 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$282,186
+2.0%
300,0000.0%0.00%
Q1 2023$276,687
+1.5%
300,0000.0%0.00%
Q4 2022$272,571
-0.2%
300,0000.0%0.00%
Q3 2022$273,000
+3.8%
300,0000.0%0.00%
Q2 2022$263,000
-41.6%
300,000
-40.0%
0.00%
Q1 2022$450,000
-0.4%
500,0000.0%0.00%
Q4 2021$452,000
-1.3%
500,0000.0%0.00%
Q3 2021$458,000
-0.9%
500,0000.0%0.00%
Q2 2021$462,000
-3.8%
500,0000.0%0.00%
Q1 2021$480,000500,0000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Opti Capital Management, LP 36,587,000$34,026,0003.65%
DeepCurrents Investment Group LLC 77,144,000$71,504,0002.14%
STEELHEAD PARTNERS LLC 28,000,000$26,028,0001.72%
Context Capital Management, LLC 13,000$12,147,0001.12%
CAMDEN ASSET MANAGEMENT L P /CA 26,324,000$24,465,0001.02%
Penn Mutual Asset Management 856$790,0000.99%
TENOR CAPITAL MANAGEMENT Co., L.P. 41,774,000$38,742,0000.84%
PFM Health Sciences, LP 23,000,000$21,372,0000.67%
AQR Arbitrage LLC 19,050,000$17,800,0000.50%
ADVENT CAPITAL MANAGEMENT /DE/ 19,910,000$18,377,0000.36%
View complete list of IONIS PHARMACEUTICALS INC shareholders